Illegal Sales in India

Gopal,Kevin;

Article

Pharmaceutical Executive

October 1, 2001

Pharmaceutical Executive

Pharmaceutical Executive-10-01-2001

Volume0

Issue 0

Illegal Sales in India

Author(s):

Kevin Gopal

Mumbai, India—The controversy over pharma companies’ incentives to pharmacists in India highlights just how competitive the Indian pharma industry has become.

Articles in this issue

National Crisis Supercedes Coverage Debate

PBMs: Merck-Medco in the Hot Seat

National Crisis Supercedes Coverage Debate

A Five-Year Forecast: Clear Seas Ahead?

Weak Bones, Strong Market

Approvals: Novartis’ Silver Lining

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Illegal Sales in India

Newsletter